BioStem Technologies's market cap is currently ―. The company's EPS TTM is $-0.443; its P/E ratio is -20.52; BioStem Technologies is scheduled to report earnings on May 20, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Income Statement	-
Total Revenue	$ 952.51K	$ 1.04M	$ 467.62K	$ 238.83K	$ 777.37K
Gross Profit	$ 736.09K	$ 656.38K	$ 210.23K	$ 31.47K	$ 353.79K
EBIT	$ -191.93K	$ -436.00K	$ -587.72K	$ -567.23K	$ -256.39K
EBITDA	$ -134.62K	$ -373.12K	$ -530.41K	$ -504.25K	$ -196.08K
Net Income Common Stockholders	$ -358.79K	$ -578.74K	$ -716.40K	$ -687.81K	$ -415.29K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 238.87K	$ 100.70K	$ 108.30K	$ 301.52K	$ 206.49K
Total Assets	$ 2.80M	$ 2.67M	$ 3.03M	$ 3.13M	$ 3.02M
Total Debt	$ 5.78M	$ 5.63M	$ 5.64M	$ 5.66M	$ 5.13M
Net Debt	$ 5.54M	$ 5.52M	$ 5.53M	$ 5.36M	$ 4.92M
Total Liabilities	$ 8.52M	$ 8.30M	$ 8.35M	$ 7.89M	$ 7.25M
Stockholders Equity	$ -5.95M	$ -5.80M	$ -5.48M	$ -4.93M	$ -4.40M
Cash Flow	-
Free Cash Flow	$ 19.18K	$ -30.93K	$ -175.62K	$ -427.03K	$ 52.02K
Operating Cash Flow	$ 19.18K	$ -30.93K	$ -175.62K	$ -427.03K	$ 52.02K
Investing Cash Flow	$ 10.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 108.98K	$ 23.34K	$ -17.61K	$ 522.06K	$ 13.73K

Currency in USD

BioStem Technologies Earnings and Revenue History

Income Statement >

BioStem Technologies Debt to Assets

Balance Sheet >

BioStem Technologies Cash Flow

Cash Flow >

BioStem Technologies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing